Related Experiment Videos
Stem cells cardiac patch from decellularized umbilical artery improved heart function after myocardium infarction.
Na Li1,2,3, RanRan Huang1,2, XiaoXia Zhang1
1Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing, P.R. China.
Bio-Medical Materials and Engineering
|April 5, 2017
Summary
This study created a 3D scaffold from decellularized umbilical artery for stem cell therapy in myocardial infarction (MI). The implanted scaffold improved cardiac function and promoted new blood vessel growth in a rat model.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Cardiovascular Research
Background:
- Stem cell therapy shows promise for myocardial infarction (MI) but requires suitable biomaterials.
- Creating vascularized 3D myocardial tissues is a significant challenge in cardiac repair.
Purpose of the Study:
- To develop a microporous 3D scaffold from decellularized umbilical artery for stem cell proliferation.
- To evaluate the efficacy of a stem cell (SC) patch in improving cardiac function after MI in a rat model.
Main Methods:
- Optimized decellularization of umbilical artery to create a 3D scaffold.
- Implanted a 5-mm microporous SC patch onto the infarct area of SD rats post-coronary ligation.
- Assessed left ventricular (LV) contractile function, wall compliance, and histology 4 weeks post-implantation.
Main Results:
- The SC patch integrated with host tissue, showing neo-vessel formation positive for CD31.
- Left ventricle wall thickness increased in the SC patch group compared to controls (p<0.05).
- Left ventricular ejection fraction (LVEF) improved significantly in the SC patch group (59±6.7%) versus the empty patch group (31±4.5%, p<0.05).
Conclusions:
- Implantation of the mesenchymal stem cell (MSC) patch enhanced cardiac contractile function in a rat model of heart infarction.
- This artificial tissue construct from decellularized umbilical artery and MSCs offers a promising approach for MI tissue therapy.